Page 2 - Markets News

Robust demand, stable pricing to keep diagnostics volumes strong in FY27

Brokerages expect diagnostic majors to sustain volume growth through FY27, aided by robust demand and stable pricing, though the recent stock rally may cap upside

Rural MF investor growth stalls as weak equity market returns take toll

Semi-urban and rural areas added just 1.3 million MF investors in FY26, down from 6.1 million in FY25, while additions in Tier II cities more than doubled

Stocks to watch: ONGC, Pine Labs, GRSE, Waaree, Lloyds Metals, Aarti Inds

ONGC struck gas at its first Mahanadi Basin well, MN-DW18-1-H-D, at a depth of 1,441-1,452 metres, around 43 km off Konark.

LIC, Axis Bank: Kotak Securities explains why they prefer these 2 stocks

Shrikant Chouhan, Head of Equity Research of Kotak Securities explains why the analyst is bullish on LIC and Axis Bank.

Lupin, Akums, Heritage Foods look relatively strong on charts: Anand James

Anand James of Geojit Investments identified three stocks Lupin, Akums Drugs and Heritage Foods with a favourable technical set-up on charts at current levels.

SP Group bonds offered at premium on Tata Sons stake-sale plan: Report

SP Group entity Eqyizen Investment had raised 213.50 billion rupees through three-year zero-coupon bonds at a yield of 18.95% in July.

98% transactions to remain unaffected by MDR on UPI: HDFC Securities

Platinum Jasmine A 2018 Trust sold 2 per cent stake in Lenskart Solutions through a block deal on Monday, worth about ₹2,391 crore

AIF commitments rise 24% to ₹17.53 trillion as of June 2026: Sebi data

AIF commitments rose nearly 3.5 per cent from March and 23.6 per cent year-on-year, while total investments crossed Rs 7 trillion for the first time

NSE IPO receives $10 billion in bids after being subscribed 5.7 times

NSE's $2.3 billion IPO ​was subscribed 5.7 times by ​the end of the final ‌day of bidding on Monday as investors bet on continued equity market growth in Asia's third-largest economy.

Stock Market Close: Sensex rises 564 pts, Nifty at 23,414; pharma, FMCG, realty top sectoral winners

Sensex Today | Stock Market Highlights, Monday: In the broader markets, the Nifty MidCap and the Nifty SmallCap fell 0.29 per cent and 0.07 per cent, respectively

Sensex jumps 690 pts intraday, Nifty tops 23,400: 4 factors behind mkt rise

Sensex today: Analysts at SBI Securities said that the gradual decline in crude oil prices over the last four trading sessions has provided some respite to Asian equities.

Solar Ind snaps 5-day losing streak, gains 4%; MOFSL initiates BUY rating

Motilal Oswal Financial Services (MOFSL) initiate coverage on Solar Industries with a BUY rating and a target price of ₹23,000.

Raymond share price jumps 9% on volume spike; stock gains 70% in a year

Raymond stock has gained 5.46 per cent over the past week, 64.43 per cent in the last month, 148.48 per cent year-to-date, and 70.42 per cent over the past year.

Unimech soars 7%, up 144% from Mar low; what's driving this defence stock?

Unimech Aerospace: The stock price of the aerospace & defence company quoted higher for the third straight trading day, surging 12 per cent during the period.

OFSS shares crack 7%; what's spooking Nifty IT's best-performing stock?

As of Friday's close, OFSS shares are up 55 per cent on a year-to-date (YTD) basis, making it the best-performing stock in the worst-performing Nifty IT index.

Nifty's 6-week losing run: 9 stocks fall 10-14%; 6 defy trend, add ₹73K cr

Bogged down by crude oil prices trading above $100, the Nifty 50 index has lost 5 per cent during the six-week selloff, which is also its longest since 2020.

Pharma stocks zoom: Laurus Labs, Aurobindo hit new highs in trade

The BSE Healthcare index rallied over 1% in Monday's trade. Thus far in the financial year 2026-27, it outperformed the market by soaring 25%, against a near 4% rise in the BSE Sensex.

Biocon spurts 3% as Pertuzumab drug moves closer to marketing nod in Europe

Biocon jumped nearly 3% in Monday's trade after the company's Pertuzumab biosimilar drug received EMA CHMP recommendation for breast cancer care.

INDO-MIM surges 21% in 3 days; up 137% from IPO price in less than 2 months

INDO-MIM's share price hit a new high of ₹1,148, soaring 9 per cent on the BSE in Monday's intra-day deals on the back of a healthy business outlook.

When will FIIs return to the Indian stock market? Bernstein answers

Another issue Bernstein highlighted was the nature of India's large-cap companies, which it believes represents a 'bygone economic era'.